Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.60 +0.06 (+1.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)

Updated

Bicycle Therapeutics (BCYC) posted Construction in Progress of $400,000 for Q2 2023.

Analysis

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023) Analysis & Trends

At the end of FY2022, Bicycle Therapeutics' Construction in Progress came in at $2.3 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Bicycle Therapeutics 249.90 Mn -2.10 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 400,000.00
Dec 31, 2022 2.30 Mn
API Access

Bicycle Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BCYC&period=max&api_key=YOUR_API_KEY